Literature DB >> 3235676

Experience with the use of pronase to eliminate interference factors in the latex agglutination test for cryptococcal antigen.

L D Gray1, G D Roberts.   

Abstract

Cryptococcal antigen titers of 70 cerebrospinal fluid and 57 serum specimens from patients suspected of having cryptococcosis were determined both before and after treatment with pronase. Median titers of cerebrospinal fluid specimens before and after treatment were 128 and 128, respectively; mean geometric titers of these specimens before and after treatment were 102 and 204, respectively. Median titers of the serum specimens before and after treatment were 16 and 512, respectively; mean geometric titers of these specimens before and after treatment were 19 and 631, respectively. The modified latex agglutination test did not detect antigen in any of 50 cerebrospinal fluid and 51 serum specimens from patients not suspected of having cryptococcosis. These results suggest that the pronase modification increases the sensitivity of the latex agglutination test and that the modification be routinely incorporated into it.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3235676      PMCID: PMC266916          DOI: 10.1128/jcm.26.11.2450-2451.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Corrected version specificity of the latex test for cryptococcal antigen: a rapid, simple method for eliminating interference factors.

Authors:  L Stockman; G D Roberts
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

2.  Septicemia due to DF-2. Cause of a false-positive cryptococcal latex agglutination result.

Authors:  M A Westerink; D Amsterdam; R J Petell; M N Stram; M A Apicella
Journal:  Am J Med       Date:  1987-07       Impact factor: 4.965

3.  Specificity of the latex-cryptococcal antigen test.

Authors:  C T Dolan
Journal:  Am J Clin Pathol       Date:  1972-10       Impact factor: 2.493

4.  Elimination of rheumatoid factor in the latex test for cryptococcosis.

Authors:  M A Gordon; E W Lapa
Journal:  Am J Clin Pathol       Date:  1974-04       Impact factor: 2.493

5.  Control for rheumatoid factor in the latex test for cryptococcosis.

Authors:  J E Bennett; J W Bailey
Journal:  Am J Clin Pathol       Date:  1971-09       Impact factor: 2.493

6.  False positive latex tests for cryptococcal antigen in cerebrospinal fluid.

Authors:  R J Hay; D W Mackenzie
Journal:  J Clin Pathol       Date:  1982-02       Impact factor: 3.411

7.  Serologic tests in diagnosis and prognosis of cryptococcosis.

Authors:  M A Gordon; D K Vedder
Journal:  JAMA       Date:  1966-09-19       Impact factor: 56.272

8.  Serum cryptococcal antigen determination in the presence of rheumatoid factor.

Authors:  R H Eng; A Person
Journal:  J Clin Microbiol       Date:  1981-12       Impact factor: 5.948

9.  Commercial cryptococcal latex kit: clinical evaluation in a medical center hospital.

Authors:  E Prevost; R Newell
Journal:  J Clin Microbiol       Date:  1978-11       Impact factor: 5.948

10.  Detection of a Trichosporon beigelii antigen cross-reactive with Cryptococcus neoformans capsular polysaccharide in serum from a patient with disseminated Trichosporon infection.

Authors:  E J McManus; J M Jones
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

View more
  17 in total

1.  Immunoreactivity of cryptococcal antigen is not stable under prolonged incubations in human serum.

Authors:  Diane C McFadden; Oscar Zaragoza; Arturo Casadevall
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

2.  Comparison of the PREMIER cryptococcal antigen enzyme immunoassay and the latex agglutination assay for detection of cryptococcal antigens.

Authors:  W Gade; S W Hinnefeld; L S Babcock; P Gilligan; W Kelly; K Wait; D Greer; M Pinilla; R L Kaplan
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

Review 3.  Serological techniques for diagnosis of fungal infection.

Authors:  L de Repentigny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

4.  False-negative cerebrospinal fluid cryptococcal latex agglutination tests for patients with culture-positive cryptococcal meningitis.

Authors:  B P Currie; L F Freundlich; M A Soto; A Casadevall
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

5.  Evaluation of an enzyme immunoassay for detection of cryptococcal capsular polysaccharide antigen in serum and cerebrospinal fluid.

Authors:  U K Frank; S L Nishimura; N C Li; K Sugai; D M Yajko; W K Hadley; V L Ng
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

6.  Effect of potential interference factors on performance of enzyme immunoassay and latex agglutination assay for cryptococcal antigen.

Authors:  H D Engler; Y R Shea
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

7.  Interference by hydroxyethyl starch used for vascular filling in latex agglutination test for cryptococcal antigen.

Authors:  L Millon; T Barale; M C Julliot; J Martinez; G Mantion
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

8.  Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.

Authors:  J Mukherjee; L S Zuckier; M D Scharff; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

Review 9.  Asymptomatic cryptococcemia in resource-limited settings.

Authors:  Ana-Claire Meyer; Mark Jacobson
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.071

10.  Evaluation of a monoclonal antibody-based latex agglutination test for diagnosis of cryptococcosis: comparison with two tests using polyclonal antibodies.

Authors:  A Temstet; P Roux; J L Poirot; O Ronin; F Dromer
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.